Health-care companies rose as traders rotated back into sectors that had led during the bull market.
BioVie shares fell despite a positive update on data from a mid-stage trial of an Alzheimer's disease candidate.
Equillium shares slid after the biotech concern agreed to to acquire smaller rival Metacrine.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
09-07-22 1659ET